Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide

This study has been terminated.

(insufficient patient recruitement)

Sponsor:

Collaborators:

Dresden University of Technology

Philipps University Marburg Medical Center

Universitätsklinikum Hamburg-Eppendorf

Hannover Medical School

Ludwig-Maximilians - University of Munich

University Hospital, Essen

Johann Wolfgang Goethe University Hospitals

Deutsche Klinik fuer Diagnostik

Charite University, Berlin, Germany

Information provided by (Responsible Party):

University Hospital Muenster

ClinicalTrials.gov Identifier:

NCT00125606

First received: July 26, 2005

Last updated: December 17, 2012

Last verified: December 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	July 2011
Primary Completion Date:	July 2011 (Final data collection date for primary outcome measure)